|
Apr 26
|
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
|
|
Apr 23
|
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
|
|
Apr 22
|
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
|
|
Apr 17
|
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
|
|
Apr 15
|
Recent 3.8% pullback isn't enough to hurt long-term Krystal Biotech (NASDAQ:KRYS) shareholders, they're still up 437% over 5 years
|
|
Apr 4
|
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
|
|
Apr 1
|
Recent Price Trend in Krystal Biotech (KRYS) is Your Friend, Here's Why
|
|
Mar 27
|
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
|
|
Mar 14
|
Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why
|
|
Mar 8
|
Can Krystal Biotech, Inc. (KRYS) Run Higher on Rising Earnings Estimates?
|
|
Mar 8
|
What Makes Krystal Biotech, Inc. (KRYS) a New Buy Stock
|
|
Mar 8
|
Krystal Biotech, Inc. (KRYS) is a Great Momentum Stock: Should You Buy?
|
|
Feb 1
|
Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference
|
|
Jan 15
|
We Think Krystal Biotech (NASDAQ:KRYS) Can Easily Afford To Drive Business Growth
|
|
Jan 4
|
Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®
|
|
Dec 20
|
Krystal Biotech, Inc. (KRYS) Moves to Buy: Rationale Behind the Upgrade
|
|
Dec 19
|
Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)
|
|
Dec 10
|
12 Best Genomics Stocks To Buy Now
|
|
Dec 7
|
Here’s Why TimesSquare Capital Management U.S. Small Cap Growth Strategy Added Krystal Biotech (KRYS)
|
|
Dec 5
|
Wall Street Analysts See a 42.55% Upside in Krystal Biotech, Inc. (KRYS): Can the Stock Really Move This High?
|